Funded Tech Companies
Silarus Therapeutics
Silarus Therapeutics, operating out of La Jolla, received equity investments from GlaxoSmithKline and Avalon Ventures.
Company Overview
Company Name
Silarus Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Company Background Information
Overview
Silarus Therapeutics is developing therapeutics targeting erythroferrone for the treatment of iron deficiency and iron overload disorders. Erythroferrone is a recently-discovered hormone that regulates the iron supply for red blood cell production.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/23/2014
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Co-Founder
Tomas Ganz
Company Investors
- GlaxoSmithKline (Lon Cardon)
- Avalon Ventures (Jay Lichter)
Browse more funded tech companies:
Sila Nanotechnologies | Silatronix
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs